Ipi/Nivo - Ipilimumab plus Nivolumab combination - Immuno Beginner

Skip to content

Home
Forums
Forum
- Log in
- Lost your password?
Updates
Tutorials
Contact us
About
Search for:

You are here:Home-Checkpoint Pathway-Immunotherapies-Ipi/Nivo – Ipilimumab plus Nivolumab combination

Ipi/Nivo – Ipilimumab plus Nivolumab combinationSteve Hoimes2020-09-23T13:52:04+10:00

Home › Forums › Checkpoint Pathway › Immunotherapies › Ipi/Nivo – Ipilimumab plus Nivolumab combination

Search for:

You must be logged in to create new topics.

Log In

Username:

Password:

Keep me signed in

Log in / Register

Sign in

Log In

Username:

Password:

Keep me signed in

Register

Topic Views Filter

Most popular topics
Topics with no replies

Forum Recent Topics

eEF2 kinase enhances the expression of PD-L1 by Steve Hoimes
4 years, 2 months ago
What is PD-L1 by Steve Hoimes
4 years, 2 months ago

Topic Tags

eEF2 PD-L1 Pdl1

Founded 2018

Immuno-Beginner founded in July 2018 by Steve Holmes, who was given 6 months to live after being diagnosed with Cholangiocarcinoma.

Immuno-Beginner has 3 primary goals

Centralize and simplify Immunology for the Newly Diagnosed patient to improve choices and decisions for all solid tumor cancers
Mutation Matchmaking to speed up patient knowledge and actions that transcend the medical communities many barriers.
Save more patients lives and their families via delivering today's life saving knowledge today!

SITE LINKS

Site Disclosure

Privacy Policy

Terms of Service

Popular Topics -Test Only

What is PD-L1
eEF2 kinase enhances the expression of PD-L1

OUR SITES

Immuno Beginner

The Cancer Tool Kit

Cholangiocarcinoma

Recent Topics

eEF2 kinase enhances the expression of PD-L1
What is PD-L1

© Copyright 2012 - | All Rights Reserved | Powered by SimpleMash

Facebook Twitter Instagram YouTube